the Effect of Danhong Injection on Microcirculation in the Treatment of Patients With STEMI After the PTCA Surgery.
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 180 participants.
Also called NCT02158559
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 180 participants
- Registry
-
NCT02158559
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- Not reported
- Countries
- Not reported
- Registry status
- Unknown status
Technical summary
Registry record NCT02158559. Randomized; double masking; primary purpose treatment. Start 2014-03 (registry gives no type); primary completion 2015-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- the Effect of Danhong Injection on Microcirculation in the Treatment of Patients With STEMI After the PTCA Surgery.
- Acronym
- Danhong
- Condition
- Myocardial Infarction
- Intervention (Drug)
- Danhong Injection
- Intervention (Drug)
- Normal Saline
- Lead sponsor
- Beijing Bozhiyin T&S Co., Ltd.
Record details
- Record id
cardio:ct-nct02158559- Content hash
00ade1bd9730a794cb11ae1e9293732b3487bb20f90f73b44454f475736b8496